| Serial Number | 79417535 |
| Word Mark | BCNPEPTIDES |
| Filing Date | Tuesday, December 24, 2024 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Tuesday, February 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific and technological services as well as research and design related thereto, namely, scientific research, development, and design services relating to pharmaceuticals; industrial analysis and research services in the field of chemistry for medical purposese; pharmaceutical research services; research and development services in chemistry; research services relating to cosmetics; pharmaceutical research and product development services |
| Goods and Services | Chemical products for use in industry specifically for biotechnological product development; chemical products for use in pharmaceutical product manufacture; chemical products for manufacturing cosmetics; biological preparations for industry and science |
| Goods and Services | Pharmaceutical products, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, of the central nervous system, namely, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, of respiratory diseases, namely, respiratory infections, asthma, bronchitis, pneumonia, of eating disorders, of musculo-skeletal disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, of urological, urogenital and urinary disorders, of dermatological diseases, namely, dermatitis, skin pigmentation diseases, psoriasis, eczema, rosacea, blotches; pharmaceutical products for medical use to treat metabolic disorders, immune conditions and disorders, inflammatory conditions, pain, infectious diseases, oncological conditions, endocrine disorders, neurological disorders, cardiovascular diseases and disorders, hematological diseases, respiratory diseases, ophthalmic diseases, diseases of the digestive system, dermatological conditions and disorders, urological diseases, gynecological conditions and conditions of the reproductive system; pharmaceutical products for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of metabolic disorders, immune conditions and disorders, inflammatory conditions, pain, infectious diseases, oncological conditions, endocrine disorders, neurological disorders, cardiovascular diseases and disorders, hematological diseases, respiratory diseases, ophthalmic diseases, diseases of the digestive system, dermatological conditions and disorders, urological diseases and conditions of the reproductive system; pharmaceutical products for skin care; hygienic and sanitary products for medical use namely, disinfectants and sanitary sterilizing preparations; dietetic substances for medical use; dietetic substances namely, dietetic preparations adapted for veterinary use, food supplements for humans and animals; biological preparations for medical and veterinary use specifically cytostatic agents, hormones, diagnostic agents for medical purposes, anti-infective agents, blood clotting agents, blood anticoagulant agents, , veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia, respiratory infections, eye infections, topical infections |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BCN PEPTIDES, S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Thursday, February 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, February 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 24, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 10, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, June 10, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 11, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, August 1, 2025 | REFUSAL PROCESSED BY MPU |
| Friday, August 1, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, August 23, 2025 | REFUSAL PROCESSED BY IB |
| Monday, February 2, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 2, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 2, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 3, 2026 | SUSPENSION LETTER WRITTEN |
| Tuesday, February 3, 2026 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, February 3, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |